NCT07216274View on ClinicalTrials.gov

Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 15, 2026

Study Completion Date

July 15, 2027

Conditions
Breast Carcinoma
Interventions
DEVICE

QT Ultrasound Breast Scanner

Undergo Quantitative Transmission Imaging (QTI) using the QT Ultrasound Breast Scanner

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT07216274 - Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer | Biotech Hunter | Biotech Hunter